GlaxoSmithKline (GSK) Consumer Healthcare has appointed Debjit Rudra as General Manager of its south-east Asia operations.
Based in Singapore, Mr Debjit will oversee GSK’s consumer healthcare business across South East Asia, reporting directly to Zubair Ahmed who heads the Asia Middle East Africa region.
He was previously Asia Vice President of Unilever’s Household Care division. He held key positions in sales, marketing and senior regional leadership roles during his 22-year tenure at the company.
Most recently, Mr Debjit assumed the role of Asia Vice President of Unilever’s Household Care division, playing a central role in the development and implementation of Unilever’s strategic roadmap for the category across Asia and ANZ.
Source: Asia Online
After more than two years of leading LEO Pharma through a major transformation and a change of capital structure in a volatile environment during the global pandemic, the Board of Directors of LEO Pharma and President and CEO Catherine Mazzacco have jointly agreed that she will resign from her current role and leave the company on November 30, 2021.
Lonza and Bioqube Ventures, a European venture capital firm with a dual investment model including venture creation, have partnered to develop and manufacture biologics and small molecules. This is a five-year services agreement in which Lonza will provide advice and services to Bioqube Ventures’ portfolio companies.
UCB has granted to Chiesi global exclusive rights to develop, manufacture and commercialize zampilimab, a monoclonal antibody targeting transglutaminase 2 (TG2), an enzyme associated in fibrotic diseases. UCB will receive upfront payment, future milestone payments and net sales royalties.
